Flow Cytometric BioAnalysis in Cell Therapy DevelopmentWebinarReplayHelping you improve your workflow in generating reproducible and submission ready flow cytometry data Flow cytometry provides an important bioanalysis method used in the development and evaluation of biotherapeutics such as CAR-T cells. The current challenge in bioanalysis lies in the generation of rigorous and reproducible data that reliably correlates to biological efficacy and is ready for FDA submission. The reproducibility crisis is often related to workflow inconsistencies in sample prep, data acquisition, and data analyses resulting in the generation of erroneous biological data that directly impact therapeutic development. Today’s webinar will discuss new technologies that address error prone steps in flow cytometry assays, reduce subjectivity and empower the generation of standardized and reproducible flow data specifically in the field of clinical research. Learning objectives:
Presented by: Dr. Alina Lelic is a Field Marketing Manager for Flow Cytometry at Beckman Coulter Life Sciences. Dr. Lelic is a trained immunologist who specialized in characterizing the human adaptive immune response to cancers and infectious pathogens and has translated her scientific discoveries in several peer reviewed journals. She has over 14 years of flow cytometry experience and prior to joining Beckman Coulter she was leading an immune monitoring laboratory at McMaster University. |
|
Processing your request... |
